We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Agilux Laboratories Appoints Head of GLP Bioanalysis
News

Agilux Laboratories Appoints Head of GLP Bioanalysis

Agilux Laboratories Appoints Head of GLP Bioanalysis
News

Agilux Laboratories Appoints Head of GLP Bioanalysis

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Agilux Laboratories Appoints Head of GLP Bioanalysis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Rich joined Agilux in early 2012 as Senior Director, Bioanalytical Operations and has also served as a member of its senior management team since that time. In his new role, Rich will be directly responsible for driving the scientific, regulatory and operational processes and improvements within its GLP bioanalytical labs.

For nearly two decades, Rich’s focus has been in regulated bioanalysis, where he has held positions of increasing operational responsibility at notable contract research organizations. Rich is an active member of the Global Bioanalytical Consortium harmonization team for small molecule bioanalysis and is a noted speaker and instructor on bioanalytical mass spectrometry throughout North America, Europe, Japan, and China. He also continues to serve as the founder and co-instructor for the High Resolution Mass Spectrometry short course at the American Society for Mass Spectrometry annual meeting.

“Rich has brought vast knowledge and GLP bioanalytical expertise to our team here at Agilux and has been instrumental in driving our scientific, regulatory and operational process improvements to enable first-class bioanalytical services,” said Jim Jersey, President and CEO. “We look forward to his future contributions and regulatory insight in this new role, and fully expect his dynamic efforts to further advance our range of GLP services for our clients.

Advertisement